GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EPIX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

ESSA Pharma Inc. stock price down 4.95% on Thursday
(Updated on Apr 18, 2024)

Sell candidate since Apr 04, 2024 Loss -17.65% PDF

The ESSA Pharma Inc. stock price fell by -4.95% on the last day (Thursday, 18th Apr 2024) from $7.07 to $6.72. During the last trading day the stock fluctuated 9.77% from a day low at $6.65 to a day high of $7.30. The price has fallen in 6 of the last 10 days and is down by -17.65% for this period. Volume has increased on the last day by 9 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 36 thousand shares were bought and sold for approximately $238.57 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.24% during the next 3 months and, with a 90% probability hold a price between $5.02 and $8.59 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EPIX Signals & Forecast

There are few to no technical positive signals at the moment. The ESSA Pharma Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $7.48 and $8.55. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, February 29, 2024, and so far it has fallen -29.26%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). ESSA Pharma Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for ESSA Pharma Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.650 between high and low, or 9.77%. For the last week, the stock has had daily average volatility of 9.84%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EPIX) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect ESSA Pharma Inc. to open at $6.89, and during the day (based on 14 day Average True Range), to move between $6.09 and $7.35, which gives a possible trading interval of +/-$0.634 (+/-9.43%) up or down from last closing price. If ESSA Pharma Inc. takes out the full calculated possible swing range there will be an estimated 18.86% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $6.80, some $0.0800 (1.19%) from the current price of $6.72, our system finds the risk reward not very attractive.

Is ESSA Pharma Inc. stock A Buy?

ESSA Pharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.010 Strong Sell Candidate Unchanged

Predicted Opening Price for ESSA Pharma Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$6.89 ( 2.53%) $6.72

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EPIX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 7.54 12.20 %
R2 7.29 8.51 %
R1 7.14 6.22 %
Current price: 6.72
Support S1 6.64 -1.17 %
S2 6.49 -3.45 %
S3 6.24 -7.14 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 8.20 22.02 %
R2 7.79 15.92 %
R1 6.80 1.19 %
Current price 6.72
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for ESSA Pharma Inc. Stock and on which exchange is it traded?
The symbol for ESSA Pharma Inc. is EPIX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ESSA Pharma Inc. Stock?
ESSA Pharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy ESSA Pharma Inc. Stock?
ESSA Pharma Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ESSA Pharma Inc. Stock.

What's the current price of ESSA Pharma Inc. Stock?
As of the end of day on the 2024-04-18, the price of an ESSA Pharma Inc. (EPIX) share was $6.72.

What is the 52-week high and low for ESSA Pharma Inc. Stock?
The 52-week high for ESSA Pharma Inc. Stock is $11.67 and the 52-week low is $2.56.

What is the market capitalization of ESSA Pharma Inc. Stock?
As of the 2024-04-18, the market capitalization of ESSA Pharma Inc. is 312.764M.

When is the next earnings date for ESSA Pharma Inc.?
The upcoming earnings date for ESSA Pharma Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About ESSA Pharma Inc.

ESSA Pharma. ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and A... EPIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT